The reality of treating dyslipidaemia in patients with coronary heart disease: a primary care survey

DJ Wright, AD Grayson, M Jackson… - International journal of …, 2003 - Wiley Online Library
Management of hyperlipidaemia in patients with ischaemic heart disease is suboptimal
despite the proven benefit of statin therapy. Significant improvement in management has …

Lipid target achievement among patients with very high and high cardiovascular risk in a lipid clinic

F Barkas, EN Liberopoulos, MS Kostapanos… - …, 2015 - journals.sagepub.com
This was a retrospective study that assessed achievement of lipid-lowering treatment targets
in the setting of a University Hospital Lipid Clinic. Low-density lipoprotein cholesterol (LDL …

16 Treatment intensity of lipid lowering therapy in high-and very high-risk patients for the prevention of cardiovascular events–baseline characteristics from the Irish …

H Rai, JJ Coughlan, S Fitzgerald, R Sheahan… - 2023 - heart.bmj.com
Introduction More stringent goals for low-density lipoprotein cholesterol (LDL-C) are
recommended for patients with high and very high cardiovascular (CV) risk according to …

Potential for cholesterol lowering in secondary prevention of coronary heart disease in Europe: findings from EUROASPIRE study

D Vanuzzo, L Pilotto, GB Ambrosio, K Pyörälä, S Lehto… - Atherosclerosis, 2000 - Elsevier
We have examined the potential for cholesterol lowering in secondary prevention of
coronary heart disease based on data from the European Action on Secondary Prevention …

Outcomes of lipid control in secondary prevention of coronary artery disease in Finland: a 24-month follow-up after acute coronary syndrome

RL Leskelä, A Torvinen, TT Rissanen, V Virtanen… - Atherosclerosis, 2020 - Elsevier
Background and aims Ischemic heart diseases are the main cause of death worldwide,
therefore secondary prevention and treatment of coronary artery disease (CAD) are highly …

Attainment of guideline recommended cholesterol goals in cardiovascular prevention results from a preventive cardio-rheuma clinic in norway

ES Sollerud, EI Ikdahl, JS Sexton… - European Journal of …, 2024 - academic.oup.com
Background There is a large gap between the European Society of Cardiology/European
Atherosclerosis Society (ESC/EAS) guideline recommendations and low-density lipoprotein …

Suboptimal treatment of dyslipidemia in clinical practice

A Gjana, E Pavli, A Kristo, D Metani… - European Journal of …, 2023 - academic.oup.com
Abstract Funding Acknowledgements Type of funding sources: None. Introduction Recent
European Society of Cardiology (ESC) guidelines on the treatment of dyslipidemia …

Effectiveness of the low‐density lipoprotein cholesterol goals in secondary cardiovascular prevention

M Garcia‐Gil, L Alves‐Cabratosa… - European Journal of …, 2024 - Wiley Online Library
Background The effectiveness of statin treatment to reduce coronary events and mortality
has been hardly examined considering goals of LDL‐C. We aimed to analyse such …

Treatment goals for blood lipids in high risk patients of atherosclerotic disease

A Svilaas, L Ose, K Risberg… - Tidsskrift for den Norske …, 2001 - europepmc.org
[Treatment goals for blood lipids in high risk patients of atherosclerotic disease]. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice

A Svilaas, K Risberg, M Thoresen… - American Journal of …, 2000 - ajconline.org
The primary objective of this study was to determine to what extent the new European
guidelines for lipid values1 were achieved in general practice in patients treated with a …